Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke (CLOTBUST-ER)

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
Cerevast Therapeutics, Inc.
ClinicalTrials.gov Identifier:
NCT01098981
First received: April 2, 2010
Last updated: April 3, 2015
Last verified: April 2015